Skip to content
MarketScale
‹ Back to IndustriesSciences

WHY 2018 IS THE YEAR TO GET YOUR DIGESTIVE TRACT BACK ON TRACK

You may be surprised to learn that your body is jam packed with trillions of bacteria. But don’t worry, most of these bacteria in your body are located in your gut, and they are actually doing good work for you! This little ecosystem, referred to as the gut microbiome, is constantly working to improve your digestion, enhance…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · Promoted Content
Share
WHY 2018 IS THE YEAR TO GET YOUR DIGESTIVE TRACT BACK ON TRACK

Key takeaways

01

You may be surprised to learn that your body is jam packed with trillions of bacteria.

02

But don’t worry, most of these bacteria in your body are located in your gut, and they are actually doing good work for you!

03

This little ecosystem, referred to as the gut microbiome, is constantly working to improve your digestion, enhance…

Get featured

Want to get featured in MarketScale Sciences?

Create a free MarketScale workspace and get your company's expertise featured across our Sciences coverage. No credit card, no demo required.

Start free

You may be surprised to learn that your body is jam packed with trillions of bacteria. But don’t worry, most of these bacteria in your body are located in your gut, and they are actually doing good work for you! This little ecosystem, referred to as the gut microbiome, is constantly working to improve your digestion, enhance your immune system, and protect you from harmful bacteria, all three of which are great reasons to focus on improving your gut health this year. The impact of gut health on overall well-being has been a very newsworthy topic in recent years. If you’ve been following the research and developments up until now, but haven’t taken the next step, then 2018 should be your year to do so, and here’s why.

The positive impact of a healthy gut has been proven time and time again. The gut microbiome contains thousands of different kinds of microbes, and is unique to each person. Strains of both good and bad bacteria exist in a delicate balance that effects your whole body. Not enough good bacteria, and functions such as digestion begin to degrade, leading to poor nutrient absorption, gas and bloating, even mental fogginess and weight fluctuations. With more good bacteria, functions such as digestion obviously improve, along with other functions that occur outside your gut, such as your ability to burn and store fat.

A healthy gut is not achieved from its bacterial make-up alone. Enzymes work with the gut microbiome to break down food into absorbable nutrients. If the body experiences a digestive enzyme deficiency, a healthy diet can go to waste as nutrients are not broken down and put to use in the body.

One of the most universally recommended methods to improve your gut health is through the use of enzymes and probiotics, good bacteria, either in foods or supplements. Without a healthy gut, a healthy diet can only go so far.

The long-term effects of a healthy gut can impact every part of your life. The GI tract is almost like a second brain, affecting moods, energy levels, libido, creative output, etc. Gastrointestinal health is extremely important to your overall well-being, which is why enzymes and probiotics are essential to restoring your intestines to a more optimal state. This can be achieved through both enzyme-rich raw foods and supplements.

But simply purchasing any supplement won’t solve your problems. When buying supplements, it is important to look at what they contain, and how much of it. When it comes to probiotics, be sure to check the specific strains and the Colony Forming Unit (CFU) number, which indicates the number of viable bacterial cells in each serving, to make sure that the supplement you choose is powerful enough to impact the flora in your gut. For enzymes, be aware that the potency of these ingredients isn’t measured in milligrams as you may be accustomed to seeing, but instead in varying Activity Units. A supplement facts panel that lists its enzymes measured by weight (in milligrams) may not have a high enough activity to make the difference you’re seeking.

Whether your preferred delivery method is foods or supplements, improving your gut health should be resolution #1 for a healthier 2018.

Deerland Enzymes & Probiotics is a leading specialty formulator and contract manufacturer of enzyme- and probiotic-based dietary supplements. With a team of industry experts working in a state-of-the-art lab, we’re positioned to serve customers from the initial stages of product conceptualization, through the design phase, and on to final formulation and contract manufacturing.

Read more at deerlandenzymes.com

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences

Follow Sciences Insights

Get new expert content in your inbox.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Sciences Insights

Pharma supplier diversification means little if every supplier uses the same airport

Pharma supplier diversification means little if every supplier uses the same airport

Biocair's Patrick Wohl argues in Pharmaceutical Commerce that life sciences firms must map airports, sea lanes, customs gateways and carriers alongside suppliers. Suppliers spread across countries can still share one air hub. The fix he describes is pre-qualified alternate routes and continuous review, with clinical trial shipments and cold-chain medicines the first cargo exposed when a corridor closes.

  • 01A supplier base spread across several countries can still be a single point of failure if every shipment routes through one airport hub or corridor; the sharper question for a logistics provider is which hubs each qualified lane actually depends on.
  • 02Gartner data cited by MD+DI gives a benchmark: 42% of procurement leaders rank supply disruption as their organization's top risk, with geopolitical issues including tariffs and regulatory changes ranking third.
  • 03A route map ages fast. Pharmaceutical Commerce published the mapping argument on July 24 and was reporting fresh Red Sea and Iran-related freight risk for pharma lanes by Aug. 10, which is the case for treating mapping as a recurring review rather than a project.

Sep 17, 2026

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Eli Lilly are investing $750 million to expand KwikPen injectable device production at Resilience's Cincinnati-region manufacturing facility, expected to create 400 high-skilled jobs and reach full operations by early 2027. The partnership builds on their collaboration since 2023, which has already produced over 150 million doses of Lilly medications for the U.S. market.

  • 01$750 million investment to expand Resilience's Ohio manufacturing capacity for Eli Lilly's KwikPen injectable device production
  • 02400 new high-skilled jobs expected in Cincinnati region, with full operations by early 2027
  • 03Partnership has already produced over 150 million doses of Lilly medications for the U.S. market since 2023

Sep 14, 2026

ENEOS ran an AI controller on a distillation column for 35 days and cut steam use 40%

ENEOS ran an AI controller on a distillation column for 35 days and cut steam use 40%

ENEOS Materials and Yokogawa ran an autonomous AI controller on a butadiene distillation column for 35 days and cut steam use 40%. It’s a real operations proof point. It also puts integration and governance gaps front and center.

  • 01A 35-day closed-loop run is a stronger autonomy proof point than a demo, it forces plants to prove handover, fallback, and KPIs over real feed and operating swings.
  • 02Steam reduction claims are compelling, but procurement and ops teams should pin vendors to baselines, operating envelopes, and how off-spec avoidance is measured.
  • 03Agentic AI is showing up as “work management” and “shift checklist” agents before it replaces control engineers, which shifts requirements toward clean, permissioned data access.

Sep 13, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512